These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15297631)

  • 1. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
    Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E
    Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.
    van Oostrom O; Velema E; Schoneveld AH; de Vries JP; de Bruin P; Seldenrijk CA; de Kleijn DP; Busser E; Moll FL; Verheijen JH; Virmani R; Pasterkamp G
    Cardiovasc Pathol; 2005; 14(3):126-34. PubMed ID: 15914297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.
    Bot PT; Hoefer IE; Sluijter JP; van Vliet P; Smits AM; Lebrin F; Moll F; de Vries JP; Doevendans P; Piek JJ; Pasterkamp G; Goumans MJ
    Stroke; 2009 Feb; 40(2):439-47. PubMed ID: 19074480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.
    Lutgens E; Gijbels M; Smook M; Heeringa P; Gotwals P; Koteliansky VE; Daemen MJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):975-82. PubMed ID: 12067907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
    Cipollone F; Prontera C; Pini B; Marini M; Fazia M; De Cesare D; Iezzi A; Ucchino S; Boccoli G; Saba V; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2001 Aug; 104(8):921-7. PubMed ID: 11514380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
    Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
    Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity.
    Ihling C; Technau K; Gross V; Schulte-Mönting J; Zeiher AM; Schaefer HE
    Atherosclerosis; 1999 May; 144(1):7-14. PubMed ID: 10381272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability.
    Jiang X; Zeng HS; Guo Y; Zhou ZB; Tang BS; Li FK
    Chin Med J (Engl); 2004 Dec; 117(12):1825-9. PubMed ID: 15603712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway.
    Gisterå A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK
    Sci Transl Med; 2013 Jul; 5(196):196ra100. PubMed ID: 23903754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
    Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
    Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
    Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
    Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery.
    Cho KY; Miyoshi H; Kuroda S; Yasuda H; Kamiyama K; Nakagawara J; Takigami M; Kondo T; Atsumi T
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):910-8. PubMed ID: 23273713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy.
    Hellings WE; Pasterkamp G; Verhoeven BA; De Kleijn DP; De Vries JP; Seldenrijk KA; van den Broek T; Moll FL
    J Vasc Surg; 2007 Feb; 45(2):289-96; discussion 296-7. PubMed ID: 17264005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques.
    Morioka M; Hamada J; Hashiguchi A; Hasegawa Y; Todaka T; Yano S; Kai Y; Miura M; Fujioka S; Ushio Y
    Surg Neurol; 2004 Oct; 62(4):292-301; discussion 301-3. PubMed ID: 15451269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased vascularization of shoulder regions of carotid atherosclerotic plaques from patients with diabetes.
    Olson FJ; Strömberg S; Hjelmgren O; Kjelldahl J; Fagerberg B; Bergström GM
    J Vasc Surg; 2011 Nov; 54(5):1324-1331.e5. PubMed ID: 21764240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis.
    Svensson PA; Olson FJ; Hägg DA; Ryndel M; Wiklund O; Karlström L; Hulthe J; Carlsson LM; Fagerberg B
    Int J Mol Med; 2008 Oct; 22(4):459-64. PubMed ID: 18813852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques.
    Hultman K; Edsfeldt A; Björkbacka H; Dunér P; Sundius L; Nitulescu M; Persson A; Boyle JJ; Nilsson J; Hultgårdh-Nilsson A; Bengtsson E; Gonçalves I
    Stroke; 2019 Nov; 50(11):3289-3292. PubMed ID: 31495329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G
    J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.
    Mallat Z; Gojova A; Marchiol-Fournigault C; Esposito B; Kamaté C; Merval R; Fradelizi D; Tedgui A
    Circ Res; 2001 Nov; 89(10):930-4. PubMed ID: 11701621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.